Comparison Overview
Sorbact® Technology
Sorbact® Technology
undefined, Mölndal, undefined, 431 30, SE
Last Update: 19/12/2025
Sorbact® Technology effectively prevents and treats wound infection across all ages, from sensitive children to elderly. Developed with a physical mode of action, bacteria irreversibly bind to the DACC™-coated surface and are safely removed. Evidence presents an antibac...
Edwards Lifesciences
One Edwards Way, Irvine, 92614, US
Last Update: 01/04/2026
Edwards Lifesciences (NYSE: EW), is the leading global structural heart innovation company, driven by a passion to improve patient lives. Through breakthrough technologies, world-class evidence and partnerships with clinicians and healthcare stakeholders, our employees ...
Compliance Ranges Comparison
Sorbact® Technology
Edwards Lifesciences
Benchmark & Cyber Underwriting Signals
Incidents vs Medical Equipment Manufacturing Industry Avg (This Year)
No incidents recorded for Sorbact® Technology in 2026.
Incidents vs Medical Equipment Manufacturing Industry Avg (This Year)
No incidents recorded for Edwards Lifesciences in 2026.
Incident History - Sorbact® Technology (X = Date, Y = Severity)
Sorbact® Technology cyber incidents detection timeline including parent company and subsidiaries.
Incident History - Edwards Lifesciences (X = Date, Y = Severity)
Edwards Lifesciences cyber incidents detection timeline including parent company and subsidiaries.
Notable Incidents
Sorbact® Technology
Edwards Lifesciences
FAQ
Latest Global CVEs
Pronetiqs IntraVUE versions 3.2.1a14 and prior have an inadequate encryption strength vulnerability which could allow an attacker to steal admin credentials via weak hash or a pass-the-hash attack.
Pronetiqs IntraVUE versions 3.2.1a14 and prior have an exposure of sensitive system information to an unauthorized control sphere vulnerability which could allow for asset discovery by unauthenticated users.
Pronetiqs IntraVUE versions 3.2.1a14 and prior have an unintended proxy or intermediary vulnerability which could allow an attacker to use an active proxy, which would bypass OT segmentation.
Pronetiqs IntraVUE Versions 3.2.1a14 and prior have a plaintext storage of a password vulnerability that could expose cleartext credentials through the API.
Pronetiqs IntraVUE versions 3.2.1a14 and prior have an exposure of sensitive system information to an unauthorized control sphere vulnerability which could expose the underlying host/share filesystem.